EFFECT OF NEBULIZED FUROSEMIDE ON VENTILATOR-FREE DAYS IN MECHANICALLY VENTILATED COPD EXACERBATION PATIENTS: A RANDOMIZED CONTROLLED TRIAL.
EFFECT OF NEBULIZED FUROSEMIDE ON VENTILATOR-FREE DAYS IN MECHANICALLY VENTILATED COPD EXACERBATION PATIENTS: A RANDOMIZED CONTROLLED TRIAL.
Created using ChatSlide
This presentation delves into a study investigating the effects of nebulised furosemide on ventilator-free days (VFD) in COPD patients. Critical insights are drawn from the use of an advanced randomised controlled trial (ARCT) design conducted in an ICU setting. We explore meticulous patient inclusion criteria to maintain trial integrity and detail both the intervention and standard care protocols. Outcome measures focus on VFD metrics, supported by robust statistical analysis. Results...